United States: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

This Time, California Governor Newsom Signs Private Equity Group And Hedge Fund Bills

California legislative activity focused upon private equity (PE) group and hedge fund health care transactions has continued notwithstanding California Governor Gavin Newsom's veto last fall of California...

United States Healthcare

M

Mintz

Update: Status Of FTC Case Against Three Largest PBMs

Following a temporary pause (which began on April 1, 2025) of the Federal Trade Commission's (FTC) administrative action against the three largest Pharmacy Benefit Managers...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

A $60 Billion Problem: Annual Medicare Losses Due To Fraud And Abuse

According to the Senior Medicare Patrol, Medicare loses an estimated $60 billion every year to fraud, errors, and abuse.

United States Healthcare

MS

Miller Shah

FDA Approves Celltrion's Aflibercept Biosimilar

On October 9, 2025, the FDA approved Celltrion's aflibercept biosimilar, EYDENZELT® (aflibercept-boav) referencing Regeneron's EYLEA® (aflibercept).

United States Healthcare

GP

Goodwin Procter LLP

Colorado Limits Medicaid Coverage Of Definitive Drug Testing

United States Healthcare

PL

Polsinelli LLP

Ohio's PBM Regulation Passed By House Of Representatives

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Benesch Healthcare+ Dialysis & Nephrology Digest No. 69

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

United States Healthcare

RG

Ropes & Gray LLP

Navigating Food And Dietary Supplements Labeling Litigation & Regulatory Hurdles In 2025 And Beyond (Video)

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

White House Announces MFN Deal With Pfizer, Previews Additional Regulatory Action On Drug Prices

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

S1 E9: Inside Sonex Health: CEO Bob Paulson On Minimally Invasive Solutions For Carpal Tunnel Syndrome (Podcast)

United States Healthcare

PL

Polsinelli LLP

WHLC Summit - Day One Recording (Video)

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

The New (And Politically Improved?) BIOSECURE Act

United States Healthcare

M

Mintz

FDCA: Fifth Circuit End-Run Suggests State Law Private Right Of Action

United States Healthcare

FL

Foley & Lardner

The Changes To The English Arbitration Regime: What Parties To International Construction Disputes Need To Know

United States Litigation

J

JAMS

AMTL's AICP Files Second Case Against TSMC, Its Advanced Memory Amends Against SK Hynix

United States IP

RC

RPX Corporation

Strengthening Your Hiring Process (Video)

United States Law Practice

OK

Offit Kurman

Unpacking A Busy Last Week For US ESG Disclosure And Compliance

United States Commercial

RG

Ropes & Gray LLP

Control, Creativity, Closure: The Mediation Advantage

United States Litigation

J

JAMS

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Update On Texas Executive Order GA-56

We recently advised you about Texas Governor Abbott's executive order GA-56, which mandated the Texas Alcoholic Beverage Commission (TABC), the Department of State Health Services...

United States Cannabis

BI

Buchanan Ingersoll & Rooney PC

Update: Status Of FTC Case Against Three Largest PBMs

Following a temporary pause (which began on April 1, 2025) of the Federal Trade Commission's (FTC) administrative action against the three largest Pharmacy Benefit Managers...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FDA Approves Celltrion's Aflibercept Biosimilar

On October 9, 2025, the FDA approved Celltrion's aflibercept biosimilar, EYDENZELT® (aflibercept-boav) referencing Regeneron's EYLEA® (aflibercept).

United States Healthcare

GP

Goodwin Procter LLP

Colorado Limits Medicaid Coverage Of Definitive Drug Testing

United States Healthcare

PL

Polsinelli LLP

Ohio's PBM Regulation Passed By House Of Representatives

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Benesch Healthcare+ Dialysis & Nephrology Digest No. 69

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Navigating Food And Dietary Supplements Labeling Litigation & Regulatory Hurdles In 2025 And Beyond (Video)

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Product Liability Considerations For Cannabis And Cardiovascular Risks

United States Cannabis

WE

Wilson Elser Moskowitz Edelman & Dicker LLP

White House Announces MFN Deal With Pfizer, Previews Additional Regulatory Action On Drug Prices

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

See more

Life Sciences, Biotechnology & Nanotechnology

Amgen And Biocon Settle Denosumab BPCIA Case

On September 30, 2025, the U.S. District Court for the District of New Jersey entered a Consent Judgment and Injunction resolving the denosumab BPCIA litigation between Amgen...

United States IP

GP

Goodwin Procter LLP

FDA Approves Celltrion's Aflibercept Biosimilar

On October 9, 2025, the FDA approved Celltrion's aflibercept biosimilar, EYDENZELT® (aflibercept-boav) referencing Regeneron's EYLEA® (aflibercept).

United States Healthcare

GP

Goodwin Procter LLP

Ohio's PBM Regulation Passed By House Of Representatives

In a previous article, Buchanan Ingersoll & Rooney discussed three pending bills in Ohio that would regulate Pharmacy Benefit Managers (PBMs), including House Bill 229.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

The New (And Politically Improved?) BIOSECURE Act

United States Healthcare

M

Mintz

FDCA: Fifth Circuit End-Run Suggests State Law Private Right Of Action

United States Healthcare

FL

Foley & Lardner

Advances In Plant Biotechnology Improving Health And Well-Being

United States IP

JA

J A Kemp LLP

BIOSECURE Included In Draft National Defense Authorization Act Of 2026

United States Healthcare

GP

Goodwin Procter LLP

EPO To Allow Color And Greyscale Patent Drawings: What U.S. Companies Need To Know

United States IP

BT

Barnes & Thornburg LLP

Celltrion Announces Launch Of AVTOZMA® (Tocilizumab-anoh) Intravenous Formulation In The United States

United States Healthcare

GP

Goodwin Procter LLP

See more

Healthcare

Shifting Trends In Healthcare Antitrust Enforcement: Navigating The Evolving Landscape

The healthcare industry has long been under the microscope of antitrust regulators, with a focus on preserving cost-effectiveness, improving access, and ensuring high-quality care.

United States Anti-trust

AV

Axinn Veltrop & Harkrider

FMLA Compliance: Tools To Curb Abuse And Protect Your Business (Podcast)

In this podcast, Heather Ptasznik (shareholder, Detroit (Metro)) breaks down the challenges of managing intermittent Family and Medical Leave Act (FMLA) leave, from spotting red flags...

United States Employment

OD

Ogletree, Deakins, Nash, Smoak & Stewart

This Time, California Governor Newsom Signs Private Equity Group And Hedge Fund Bills

California legislative activity focused upon private equity (PE) group and hedge fund health care transactions has continued notwithstanding California Governor Gavin Newsom's veto last fall of California...

United States Healthcare

M

Mintz

Update On Texas Executive Order GA-56

United States Cannabis

BI

Buchanan Ingersoll & Rooney PC

Update: Status Of FTC Case Against Three Largest PBMs

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

A $60 Billion Problem: Annual Medicare Losses Due To Fraud And Abuse

United States Healthcare

MS

Miller Shah

Colorado Limits Medicaid Coverage Of Definitive Drug Testing

United States Healthcare

PL

Polsinelli LLP

Ohio's PBM Regulation Passed By House Of Representatives

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Benesch Healthcare+ Dialysis & Nephrology Digest No. 69

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

See more

Latest Videos

See more

Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)

RG

Ropes & Gray LLP

WHLC Summit - Day One Recording (Video)

SM

Sheppard Mullin Richter & Hampton

Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)

AM

Alvarez & Marsal

Navigating Women's Health With Rachel Welch (Video)

OK

Offit Kurman

Inside MedTech Translation Challenges: Ensuring Multilingual Regulatory Compliance

Moringside

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More